Forest offers a variety of therapies that can provide a meaningful benefit to people's
lives. Our diverse range of prescription products includes:
FETZIMA™ (levomilnacipran extended-release capsules),
NAMENDA® (memantine HCl),
NAMENDA XR® (memantine HCl),
SAVELLA® (milnacipran HCl),
TEFLARO® (ceftaroline fosamil) for injection,
TUDORZA® PRESSAIR® (aclidinium bromide inhalation powder), and
VIIBRYD® (vilazodone HCl).
View a complete list of our products.
If you are a healthcare professional and have a question or need information
about a specific Forest product, please contact Forest's Medical Information and
Communication Department at 800-678-1605,extension 66297.
If you have questions regarding any Forest product, please contact your healthcare provider.
are registered trademarks of Forest Laboratories, Inc.
AEROCHAMBER PLUS®, and
are registered trademarks of Trudell Medical International.
CAMPRAL® is a registered trademark of Merck Santé.
DALIRESP® is a registered trademark of Takeda GmbH.
FETZIMA™ is a trademark of Forest Laboratories, Inc.
LINZESS® is a registered trademark of Ironwood Pharmaceuticals, Inc.
MONUROL® is a registered trademark of Zambon S.p.A.
NAMENDA® and NAMENDA XR® are registered trademarks of Merz Pharma GmbH & Co. KGaA.
TIAZAC® is a registered trademark of Valeant International SRL.
TUDORZA® and PRESSAIR® are registered trademarks of Almirall, S.A.
With a unique partnership-focused business model and a strong track record
of commercial achievement, Forest has built a pharmaceutical business for
today's environment. The Company is fulfilling its objective of making a
meaningful difference in patients' lives through an expanded and diversified
product portfolio and the most robust pipeline in our history.
Forest employees are driven by a shared passion to help improve patients' lives
through medicine. Forest offers a variety of opportunities for experienced professionals,
sales professionals, graduate students, and others to build their careers in a
about joining our team.
Thank you for visiting www.FRX.com.
You are now being redirected to an external site.